Meet Neffy, the Friendly Epinephrine Nasal Spray from ARS Pharma Awaiting FDA Approval

Meet Neffy, the Friendly Epinephrine Nasal Spray from ARS Pharma Awaiting FDA Approval

Having a life threatening allergy is scary. That was the advertising approach taken in 2016 by Epi-Pen maker Mylan with their “Face Your Risk” awareness campaign. ARS Pharma is taking a different approach with their epinephrine nasal spray, going for a friendly approach and the first step in that is naming of the spray, Neffy.

ARS Pharma logo

by Beth Snyder Bulik
Sep 3, 2021

Friendly epinephrine? Meet Neffy, ARS Pharmaceuticals’ nasal spray epinephrine to treat severe allergic reactions to food, medicines and insect bites.

Neffy, now awaiting FDA approval, aims to flip the script on past epinephrine autoinjector marketing that focused on fear around the severe reactions called anaphylaxis. Anaphylaxis is indeed scary—hives, extreme swelling, breathing difficulties, loss of consciousness and even death can happen quickly.

Remember the chilling 2016 “Face Your Risk” awareness campaign from Epi-Pen maker Mylan, now Viatris? Its TV ad featured a teenage girl at a party who accidentally eats a brownie with peanut butter, showing her rapid descent into anaphylaxis as her friends panic around her.

Continue Reading

What to Do If You Can’t Afford Epinephrine Auto-Injectors

Having an allergy can be challenging and inconvenient. When it’s life threatening it can be deadly. We know that epinephrine helps stop attacks of anaphylaxis; it’s vital that individuals at risk have access. But what do you do when the costs make that access difficult? To help with affordability the manufacturers of epinephrine auto-injectors have extended their savings program through 2021. In addition there may be other steps you could take to help lower your cost of epinephrine auto-injectors (EAI) devices.

What to Do If You Can’t Afford Epinephrine Auto-Injectors

Doctor's stethoscope on Greenback Bills

Kids With Food Allergies 3/5/21

The manufacturers of epinephrine devices have extended their U.S. savings programs through 2021.

Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis [anna-fih-LACK-sis]. It is only available through a prescription by your doctor. Each prescription comes with two auto-injectors in a two-pack.

Continue Reading

Intranasal Delivery of Emergency Epinephrine Takes Another Step Toward Realization

Concerning anaphylaxis emergencies and epinephrine, imagine if an "Epi nasal spray" became a viable treatment option instead of an intermuscular EAI injection device. It might happen sooner that you might think; new devices are being developed that don't require using a needle. And some of them do look very promising.

Intranasal Delivery of Emergency Epinephrine Takes Another Step Toward Realization

Intranasal Epi device

Dave Bloom By Dave Bloom
2021/07/07

We’ve been following the progress of ARS Pharma’s and Bryn Pharma’s intranasal emergency epinephrine devices as they make their way through clinical trials. These devices are meant to provide a needle-free alternative to today’s auto-injectors for the treatment of anaphylaxis.

Now, yet another company is reporting promising results in the race to bring an intranasal device to market, although this one does so differently.

Nasus Pharma based in Tel Aviv is reporting positive results from a pilot study of their FMXIN002 candidate. Unlike the other devices, this device stores and delivers epinephrine in powder form.

According to Nasus, the pilot study is the first human study of powder epinephrine and provides additional compelling evidence to the robustness of their intranasal powder technology in addition to the recently published results of their intranasal naloxone study.

Continue Reading

‘Most People’ Find Allergen Labels Unclear as Precautionary Labelling Spreads Confusion

Have you ever read a food label, looking for information on potential allergens and weren’t sure what was and wasn’t in the item? You’re not alone and if you suffer from a life threatening allergy, that confusion could be deadly. A new study showed that less than half people found the messaging clear when it came to allergens on food labels. The importance of accurate and clear food labeling is essential to helping those with allergies navigate their food choices and to staying safe.

‘Most People’ Find Allergen Labels Unclear as Precautionary Labelling Spreads Confusion

Mother and little girl - food allergin label confusion

Katy Askew
28-Jul-2021

As a new study reveals, the majority of people find allergen labels confusing. What's the problem and what should be done?

When researchers from The Netherlands evaluated consumer understanding of allergy information on food labels, less than half of people found the messaging clear.

The study, published in journal Clinical & Experimental Allergy, involved two separate experiments with a total of 96 consumers with food allergies and 105 without.

Investigators first randomly presented 18 different food products with labels suggesting peanut was, may be, or was not an ingredient. They then presented three different formats of information: 'Produced in a Factory' and 'May contain' or 'Traces of'.

Continue Reading

Keven Moore: My near death experience with a peanut allergy shared so you understand the gravity

A life threatening allergy is just that, life threatening. For individuals that have them and their loved ones, a state of hyper vigilance is a constant. From diligently examining food labels. to concerns about cross contamination in restaurants, these individuals strive to stay safe. But sometimes an anaphylaxis reaction occurs. Here Kevin Moore has shared his near death experiences caused by his peanut allergy. He helps us understand what it is like to experience an anaphylaxis attack and in doing so provides us the incentive to become hyper vigilant as we strive in helping those suffering from life threatening allergies.

Keven Moore: My near death experience with a peanut allergy shared so you understand the gravity

Emergency Sign

By Keven Moore
May 20th, 2021

-published by the North Kentucky Tribune-

As a safety and risk management professional, I have a confession to make. I have had a total of five workers’ compensation claims in my lifetime. Yes, five. One minor laceration that required three stitches during my teenage years at McDonald’s, a twisted ankle at UPS, and one broken rib from an altercation trying to stop a shoplifter at McAlpin’s all while I was in school.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2020 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions